MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

A Young Patient with Paroxysmal Choreoathetosis

D. Di Luca, A. Milesi-Halle (Miami, FL, USA)

Meeting: MDS Virtual Congress 2020

Abstract Number: 65

Keywords: Chorea (also see specific diagnoses, Huntingtons disease, etc): Clinical features

Category: Choreas (Non-Huntington's Disease)

Objective: To describe a rare pediatric movement disorders.

Background: The differential diagnosis of paroxysmal movement disorders in children are broad and challenging. Early recognition by neurologists and movement disorders specialists is pivotal for early management.

Method: Here we present a case of a patient with a rare pediatric movement disorders.

Results: A 13-year-old boy with a complex medical history, including primary generalized epilepsy with seizure onset at 8 months of age, spastic quadriplegia, global developmental delay and intellectual disability, presented with paroxysmal choreoathetoid movements in the setting of influenza infection. Over his lifetime, he has had four severe episodes of abrupt onset of choreoathetoid movements induced by viral infections, typically Influenza. The latest episode was noted in August 2019 when he was found to be mycoplasma positive. His movements were severe enough to cause rhabdomyolysis and acute renal Injury, requiring pharmacological paralysis and intubation for further ventilator support.  He was treated with a variety of medications, including short and long-acting benzodiazepines, alpha-agonists, monoamine-depleting agents like tetrabenazine, trihexyphenidyl, as well as antiepileptics. Although the patient first developed seizures at 8 months of age, periods of movement exacerbation were not accompanied by increase in seizure frequency, and he was well controlled in monotherapy with Levetiracetam.  Prolonged EEG and MRI Brain were unremarkable, with no evidence of seizures or structural lesions. Further evaluation with whole-exome testing revealed a de novo heterozygous variant c.625C>T, p.Arg209Cys in the GNAO1 gene.

Conclusion: GNAO1 mutations are a rare and recently described condition, usually associated with developmental delay, epileptic encephalopathy and paroxysmal movement disorders. The clinical description and phenomenology of this movement disorder is not yet defined with very few cases report in the literature (less than 60 patients to our knowledge). Here we present a detailed video case of a patient with paroxysmal choreoathetosis with epilepsy and global developmental delay. Additionally, pediatric movement disorders is a relatively new and growing field of neurology, with increasing need for continuous research and clinical characterization. Early recognition of this condition by neurologists and movement disorders specialists is pivotal for early diagnosis and appropriate management.

To cite this abstract in AMA style:

D. Di Luca, A. Milesi-Halle. A Young Patient with Paroxysmal Choreoathetosis [abstract]. Mov Disord. 2020; 35 (suppl 1). https://www.mdsabstracts.org/abstract/a-young-patient-with-paroxysmal-choreoathetosis/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to MDS Virtual Congress 2020

MDS Abstracts - https://www.mdsabstracts.org/abstract/a-young-patient-with-paroxysmal-choreoathetosis/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley